Does a social prescribing ‘holistic’ link-worker for older people with complex, multi-morbidity improve well-being and frailty and reduce health and social care use and costs? A 12-month before and after evaluation by Asthana, S et al.
1 
 
Does a social prescribing ‘holistic’ link-worker for older 
people with complex, multi-morbidity improve well-being 
and frailty and reduce health and social care use and costs? A 
12-month before and after evaluation 
 
 
Authors: Julian Elston1, Felix Gradinger 2, Sheena Asthana3, Caroline Lilley-Woolnough4, Sue 
Wroe5, Helen Harman6 and Richard Byng7  
 
Authors’ details 
1,2 Researcher-in-Residence, Torbay and South Devon NHS Foundation Trust (TSDFT), 
Torbay, UK and Research Fellow, Community and Primary Care Research Group (Faculty of 
Medicine and Dentistry), Plymouth University, UK 
3 Professor, School of Law, Criminology and Government (Faculty of Business), Plymouth 
University, UK  
4 Project Development Manager, Torbay and South Devon NHS Foundation Trust (TSDFT), 
Lowes Bridge, Torquay, UK 
5 Chief Officer, Teignbridge CVS, Newton Abbot, Devon, UK  
6 Chief Officer, Age UK Torbay, Torbay, UK 
7 Professor, Community and Primary Care Research Group (Faculty of Medicine and 
Dentistry), Plymouth University, UK 
 
Contributions:  
JE and FG: evaluation design, quantitative and qualitative data analysis and writing 
SA: quantitative data analysis and writing  
CLW: evaluation design, quantitative data collation, analysis and writing  
SW: evaluation design, data collection and analysis 
HH: evaluation design, data collection and analysis 
RB: quantitative data analysis and writing 
 
Key words: social prescribing; holistic link-worker; older people; patient activation measure; 
frailty; Researcher-in-Residence 
 
Correspondence to: Dr Julian Elston, Community and Primary Care Research Group (Faculty 
of Medicine and Dentistry), Plymouth University, UK. Email: julian.elston@nhs.net 
 
Conflicts of interest: This evaluation was supported by Torbay Medical Research Fund and 
Torbay and South Devon NHS Foundation Trust (TSDFT). TSDFT also commissioned the social 
prescribing service (managed by Sue Wroe and Helen Harman) and part-funded the 
Researchers in Residence (Julian Elston and Felix Gradinger) with Torbay Medical Research 
Fund (TMRF project number 120). Julian Elston and Felix Gradinger are employed by 
Plymouth University. 
 
 
2 
 
Consent and approval: Service users were consented for the use of their health outcomes 
and primary and secondary care service activity data in a service evaluation. The evaluation 
was supported by university-employed Researchers-in-Residence holding honorary positions 
with Torbay and South Devon NHS Foundation Trust, operating under ethics granted by the 
NHS Health Research Authority (Research Ethics Committee reference: 17/LO/1745; 
Protocol number: PSMD-208147-SA-FG-034; Integrated Research Application System project 
ID: 208147). 
 
Acknowledgements: Teignmouth CVS, Age UK Torbay, Neil Elliot, Stephen Honeywill, 
Catherine Williams, Guy Mollet, Torbay and South Devon NHS Foundation Trust, South 
Devon and Torbay CCG, and service users and staff involved in delivering the social 
prescribing services across South Devon and Torbay. 
 
 
  
3 
 
Abstract  
Aim: To evaluate the impact of ‘holistic’ link-workers on service users’ well-being, activation 
and frailty, and their use of health and social care services and the associated costs. 
Background: UK policy is encouraging social prescribing (SP) as a means to improve well-
being, self-care and reduce demand on the NHS and social services. However, the evidence 
to support this policy is generally weak and poorly conceptualised, particularly in relation to 
frail, older people and patient activation. Torbay and South Devon NHS Foundation Trust, an 
integrated care organisation, commissioned a Well-being Co-ordinator service to support 
older adults (≥50 years) with complex health needs (≥ 2 long-term conditions), as part of its 
service re-design. Methods: A before-and-after study measuring health and social well-
being, activation and frailty at 12 weeks and primary, community and secondary care service 
use and cost at 12 months prior and after intervention. Findings:  Most of the 86 
participants achieved their goals (85%). On average health and well-being, patient activation 
and frailty showed a statistically significant improvement in mean score. Mean activity 
increased for all services (some changes were statistically significant). Forty-four per cent of 
participants saw a decrease in service use or no change. Thirteen high-cost users (>£5,000 
change in costs) accounted for 59% of the overall cost increase. This was largely due to 
significant, rapid escalation in morbidity and frailty. Co-ordinators played a valuable key-
worker role, improving the continuity of care, reducing isolation and supporting carers. No 
entry-level participant characteristic was associated with change in well-being or service 
use. Larger, better-conceptualised, controlled-studies are needed to strengthen claims of 
causality and develop national policy in this area. 
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Introduction 
In the UK, an ageing population combined with a growing number of people living with 
long-term medical conditions is increasing demand and cost pressures on the acute, primary 
and social care services (Wanless et al., 2006; Licchetta and Stelmach, 2016). Large cuts to 
social service funding (31% real terms between 2011-16) (Harris, 2017), stagnating health 
service budgets due to austerity and concerns about projected levels of funding deficits 
(Dyson, 2014) have led to policy calls for the re-design of health and social care services. A 
key demand has been for services to become more integrated to better serve the complex 
needs of the older, frail population and to be more focused on encouraging supported self-
management, as a means to reduce demand on primary and secondary care services, making 
them more sustainable (Dyson, 2014; NHS England, 2014, 2016a; b). 
 
One innovation that has been consistently advocated for is social prescribing (Department of 
Health, 2006; NHS England, 2016a). This is now reflected in the appointment of a national 
General Practitioner (GP) clinical champion (Matthews-King, 2016). It is estimated that 20% 
of GP appointments have a social element (Parkinson and Buttrick, 2015; Matthews-King, 
2016), but GP capacity to address social problems that precipitate and perpetuate ill health 
are often limited (Popay et al., 2007). Social prescribing is a way of connecting patients to 
practical, community-based support, including access to advice on employment, housing and 
debt (NHS England, 2016a), as a means of addressing their social, health or economic needs, 
and promoting well-being and independence. In this way it is also seen as a way of improving 
the integration of health and social care, improving patients’ experience (Wilson and Booth, 
2015) and reducing demand on primary and acute care service, as well as contributing to 
other government objectives in relation to employment, volunteering and learning (The 
King's Fund, 2018). However, few studies have focused on an older, frail cohort with long-
term morbidity. 
 
Furthermore, there is no agreed definition of social prescribing, and models of delivery differ 
significantly across the UK in relation to the actual activities offered (health, social and 
economic), and with regards to the level of support given to patients following referral 
(Moffatt et al., 2017). For example, social prescribing can range from simple sign-posting to 
a non-medical local service or a community group by a GP or member of the primary care 
team, to referral to a link-worker. Link-workers, sometimes based in a GP practice, help 
determine the person’s needs and connect them to an appropriate local service or resource 
(Kimberlee, 2015; Husk et al., 2016; Social Prescribing Network, 2016).  This role can also 
vary from ‘light-touch’ (referring people to community assets, typically voluntary transport, 
befriending, advocacy services) to ‘holistic’(Kimberlee, 2015), a more instrumental, person-
centred approach that engages the individual to identify their needs, set well-being goals, and 
provide practice and emotional support to address these over a period of time, typically three 
months (Kimberlee, 2015).  In contrast to the ‘light-touch’ approach (typically reported in 
UK studies), which could increase dependency on primary care for addressing social 
problems and welfare needs (Cawston, 2011), the ‘holistic’ model aims to improve a patient’s 
self-efficacy and capacity to maintain or improve their health and well-being over the longer 
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term. This is primarily achieved through the relationship with a trained (non-clinical) link-
worker. Key elements of this relationship are an open, trusting, non-judgemental, long-term, 
person-centred relationship, whereby the link-worker acts as a flexible coach, facilitator and 
patient advocate for support and personal change (Moffatt et al., 2017; Polley et al., 2017b). 
 
In Torbay and South Devon, the Integrated Care Organisation, a provider organisation, 
commissioned a social prescribing service from the voluntary sector to be integrated into its 
five locality hubs, alongside primary care, community and social services. Those referred to 
the service receive an initial strengths-based, guided conversation to determine whether a 
‘light touch’ or ‘holistic’ approach was required. It was assumed that social prescribing 
would not only improve patients’ mental well-being and ‘activate’ them to better self-manage 
their health, but would also lead to reduced demand on primary and acute health care and 
social care services. Studies show that the level of patient activation is a predictor of health 
care utilisation and cost (Hibbard et al., 2013; Blakemore et al., 2016). 
 
However, recent literature reviews on social prescribing suggest that the evidence base to 
support these assumptions is small, inconclusive and weak (Bickerdike et al., 2017; Moffatt 
et al., 2017; Polley et al., 2017a).  Only 15 studies were identified with some form of link-
worker and these were limited by poor design and reporting (such as small numbers, lack of 
controls, use of validated measures, short follow-up) and encompassed a mix of delivery 
models, making them difficult to compare or synthesize (Social Prescribing Network, 2016). 
Furthermore, many studies failed to disentangle the processes of programme enrolment from 
the nature of link-worker engagement and adherence to referred activities (Husk et al., 2016) 
when evaluating effectiveness, making it difficult to attribute causality to these differing 
components of social prescribing (Husk et al., 2019).  
 
Although studies generally showed positive results, with reports of improvements in health 
and well-being outcomes, some reductions in use of primary and acute health care and a 
reduction in costs to the NHS or wider system, many results were not clinically or statistically 
significant and at a high risk of bias (Moffatt et al., 2017). There was little or no evidence on 
physical health, patient activation, impact on frailty or use of out-patient, community and 
social care services or their associated costs. 
 
This study sought to evaluate the impact of a ‘holistic’ link-worker on older patients with 
multiple long-term conditions across three localities in South Devon. The primary hypothesis 
was that the intervention would improve health and social well-being, patient activation and 
frailty levels, and that this would lead to less use of primary, social and acute care services 
and reduced costs. A secondary objective was to explore what patient characteristics on 
programme entry were associated with positive outcomes.  
 
Methods 
 
Study design 
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A 12-month before and after study followed people receiving the 12-week intensive coaching 
programme delivered by a Well-being Co-ordinator or ‘holistic’ link-worker in a setting 
preferred by the person.  
 
Setting 
South Devon is a coastal and moorland area consisting of 140,600 people, mainly resident in 
six market and coastal towns.  It has a higher proportion of people over the age of 60 
compared to England, and some pockets of deprivation. 
 
The Well-being Coordination service uses 12 Co-ordinators employed by seven key 
voluntary sector organisations, embedded in local communities across the area. Co-ordinators 
are based in a variety of settings, including NHS premises. This study focuses on the South 
Devon service commissioned by Torbay and South Devon NHS Foundation Trust and 
managed by Teignbridge CVS, an umbrella voluntary sector organisation. Although the 
Torbay service (funded by the national lottery and managed by Ageing Well Torbay) 
operates in a similar way, it was not included as it had its own evaluation.  
 
Intervention 
The Co-ordinators hold an initial 30-40 minute strengths-based, guided conversation with all 
referrals, mostly in their homes (80%), to determine need and decide whether sign-posting, a 
short-conversation or a more in-depth ‘holistic' conversation is required. The latter uses a 
range of tools over several meetings to enable the person referred to understand what matters 
to them and set goals for living well. The Co-ordinator then works with the individual for up 
to 12 weeks to enable them to take action to achieve their goals. This includes resilience-
focused coaching and practical support and advocacy to navigate and access local health, 
social and economic services. This study focuses just on those participants receiving the more 
intensive ‘holistic’ intervention (see Figure 1). 
 
All Co-ordinators are non-health care staff (although some previously worked in the health 
service) and all received training in goal-setting, use of tools and outcome measures, and in 
how to engage with users in a strengths-based way, co-produce a plan and manage risk. Key 
aspects of the role included: listening skills, emotional support, advice and practical 
assistance and coaching.  
 
Participants 
Individuals aged 50 years or over with two or more long-term conditions, considered as likely 
to benefit from a social intervention. Referrals were received mainly from statutory services –
GPs, community and social care staff in multi-disciplinary meetings, hospital discharge staff 
(acute and community) and housing staff – as well as local voluntary and community 
organisations. Figure 1 shows the referral routes and the focus of the study.  
 
Variables  
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Data on age, sex, referral route was recorded on referral forms and health outcomes collected 
at either the first or second meeting with the Co-ordinator and after 12 weeks support (or the 
point of exit). The following validated health outcome measures were used:  Well-being 
Star™ (seven domains, each scoring 1 to 10), Patient Activation Measure (PAM)® (13 items, 
scoring 0 to 100, or levels 1 to 4)  and Warwick-Edinburgh Mental Health and Well-being 
Scale (WEMWBS) (14 Likert questions, each scoring 1 to 5) (Tennant et al., 2007 ) and the 
Rockwood Clinical Frailty Scale (RCFS) (scoring 1 (very fit) to 10 (terminally ill), with  
frailty ≥5) (Rockwood et al., 2005). 
 
Referrals from GP practices, social care staff and voluntary sector organisations were 
categorised as Community referrals, and those from acute services or intermediate care multi-
disciplinary teams (MDT) as Complex referrals. 
 
Data sources/ measurement  
Data on the use of health and social care services was collated from local IT systems 12 
months prior to and after the date of each referral. It included the following services: accident 
& emergency (A&E) and minor injury units (MIU), in-patient, out-patient, community 
service (i.e. occupational therapy, physiotherapists and nursing) and social service contacts 
and length of stay (in-patients only) and GP contacts. Contacts outside the CCG boundary 
were also included. 
 
Cost data 
The cost analysis was based on health and community service attendance 12 months before 
and after the intervention. It used the Trust’s attendance costs submitted to the National Tariff 
Payment System for 2016-17, rounded to the nearest £10, and where this involved an 
admission, was multiplied by length of stay (days). Costs included overheads (i.e. building 
and maintenance (including equipment), administration and back-office staffing costs), and 
nurse and doctor time (except in-patient costs) (Monitor and NHS England, 2016). 
Diagnostics costs were not included. Local estimates were: A&E (£80), in-patient care (£300 
per day), out-patient (£100) and community services (£70). Social care costs were based on 
actual expenditure, using figures from contract arrangements with social services.  The per 
person cost of the WBC service was not included in calculations.  
 
Bias 
Data was collected by the same link-worker and returned to the administrator. The NHS 
number was used as the key identifier for health and social care use. Researchers were blind 
to the participants. Data was collected for 12 months before and after the intervention to 
minimise the effects of seasonality (as this was a new service).  
 
Study size   
The study size calculation was based on the effect seen in the Cornwall Pathfinder social 
prescribing pilot (23% increase WEMWBS) (Cell Consulting Ltd, 2015; Murray, 2016), and 
a standard deviation of 8.97 (12.5%) drawn from population studies (Stewart-Brown and 
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Janmohamed, 2008), as this was not provided in current studies. Powered at 80% and a 5% 
significance level, the study would require 170 people to be statistically conclusive; roughly 
equivalent to the first six months of participants (1 July-31 December 2016) 
 
Statistical methods 
The health outcomes and health and social care service use and cost were analysed by mean 
change in outcome or service contacts or costs 12 months before and after the first point of 
contact with the link-worker. For metric and interval outcomes (WEMWBS, Well-being Star 
and PAM) a paired t-test was used to test for significance, if the Shapiro-Wilks test for 
normality was not significant (Ghasemi and Zahediasl, 2012). Non-normally distributed 
metrics and interval outcomes and ordinal outcome measures (age band, PAM level, RCFS 
and Goals) were tested using the Wilcoxon matched-pair signed-rank test. Categorical 
outcomes such as referral route (acute and community) were analysed using the two-sample t 
test or the Mann Whitney test, if either analytic arm was identified as not normally 
distributed. Where more than two categories were analysed the X
2
 test was used. For bivariate 
linear regression the Pearson r correlation test was used, where both metric variables were 
normally distributed. Ordinal correlations used the Spearman rank correlation.  
 
To analyse the impact of age, referral route, PAM level and RCFS score on entry on health 
and social care costs, a multiple regression model was developed. Each variable tested for 
statistical significance before inclusion in the model, until the best fit was determined. Due to 
the small numbers of individuals with missing variables (age n=1, PAM Level: n=5) or 
without 12-month post intervention, health service data were not imputed for that variable or 
used in the modelling. All analyses were undertaken in SPSSv24. 
 
Consent and ethical approval 
Service users were consented for the use of their health outcomes and primary and secondary 
care service activity data in a service evaluation. The evaluation was supported by university-
employed Researchers-in-Residence holding honorary positions with Torbay and South 
Devon NHS Foundation Trust, operating under ethics granted by the NHS Health Research 
Authority (Research Ethics Committee reference: 17/LO/1745; Protocol number: PSMD-
208147-SA-FG-034; Integrated Research Application System project ID: 208147). 
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 Figure 1. Referral routes and focus of study  
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Figure 2. Flow diagram of study participants 
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Findings 
Participants and characteristics 
There were 1,046 participants; 251 were referred in the first six months, 151 (60%) were 
triaged to receive a longer, guided conversation and the 12-week programme. Figure 2 shows 
the referral route and numbers entering the ‘holistic’ service in the first six months. There 
was a wide variation in triage rates by voluntary sector providers (12%-72%). 
 
A total of 126 participants had health outcomes data. However, only 86 (68%) had a full 12 
months’ worth of health and social care data after the first point of contact. Outcome data was 
missing on five variables in 13 individuals: age (1), PAM score (5), Well-being Star (4) and 
RCFS score (4) and referral source (1).  
 
Table 1 shows that the age distribution was negatively skewed towards the elderly, with a 
mean of 79.6 years (median of 82.2 years with range 52.7-94.5), older than in other studies. 
(Grant et al., 2000, Grayer et al., 2008; Friedli et al., 2012; Dayson and Bashir, 2014; Bertotti 
et al., 2015; Farenden et al., 2015; Kimberlee, 2016; Windle et al., 2016). Participants were 
lowly activated with nearly three-quarters with PAM scores at Level 1 and 2, 11% higher 
than population estimates in over 65 year-olds with one or more long-term conditions (PAM 
Level 1, 16% and PAM Level 2, 45%) (Blakemore et al., 2016).The RCFS scores varied 
between 1 to 9. This was not normality distributed, with a median and mode of 4, with most 
people falling into the categories of vulnerable, capable of limited activities but not 
dependent on others (4) to moderately frail (6), requiring help with outside activities and 
house-keeping. In relation to health and social care use, most distributions were positively 
skewed, with 45 (52.3%) participants having had no A&E contacts in the year prior to the 
intervention, 48 (55.8%) no in-patient care, 22 (25.6%) no out-patient care, 25 (29.1%) no 
community care and 75 (87.2%) no social care contact. Multiple use of different types of 
health and social care services was more normally distributed, with a mean of 2.5, varying 
from 10 participants with no contact to nearly a third of participants (30.3%) contacting 4 or 
5 kinds of services, which together represent a disproportionate 2,624 contacts (66.7% of the 
total) in the year before entry into the programme. 
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Table 1. Participant demographics and entry-level outcomes variables 
  
Variable No. of people (%) Variable No. of people (%) 
Age band in years (n=85 )  PAM (n=81)  
    50-59   5 (5.8%) Score Level  
    60-69 10 (11.6%)  Level 1  42 (51.9%) 
    70-79 23 (26.7%)  Level 2 19 (23.5%) 
    80-89 38 (44.2%)  Level 3 14 (17.3%) 
    90+   9 (10.4%)  Level 4   6 (7.4%) 
Sex  (n=86)  Referral type (n=85)  
  Female 63 (73.3%) Community  48 (55.8%) 
  Male 23 (26.7%) Complex  37 (43.0%) 
Referral route (n=86)  HSC use (≥1) (n=86)  
  GP 21 (24.4%)  A&E/MIU 41 (47.7%) 
  Hospital discharge   7 (8.1%)  In-patient 38 (44.2%) 
  MDT 28 (32.6%)  Out-patient 64 (74.4%) 
  MDT SC   4 (4.7%)  Community 61 (70.9%) 
  Other statutory   2 (2.3%)  Social care 11 (12.8%) 
  Self-referral   6 (7.0%) Multiple HSC use (n=86)
 
  
  Voluntary sector 17 (19.8%)  0  10 (11.6%) 
RCFS score (n=83)   1 13 (15.1%) 
 Score ≤3   7 (8.4%)  2 19 (22.1%) 
 Score   4 36 (43.3%)   3 18 (20.9%) 
 Score   5 11 (13.3%)  4 20 (23.3%) 
 Score ≥6 29 (35.0%)  5   6 (7.0%) 
 
Key: GP (General practice); MDT (multi-disciplinary team); MDT SC (MDT social care); RCFS (Rockwood Clinical Frailty Scale); PAM (Patient Activation Measure); HSC (Health and Social Care); 
A&E (Accident and Emergency).  
 
 
 
 
 
13 
 
Health outcomes 
Table 2 shows the mean change in health outcomes on entry and at 12 weeks or exit. Goal 
achievement and all health and social outcomes showed statistically significant change. The 
average number of goals per participant was 3.2 (median 3; range: 1-7), with most people 
(85.3%) achieving their goals in 12 weeks. Participants’ average WEMWBS score on entry 
was 38.8, compared to a population mean of 51 (Stewart-Brown and Janmohamed, 2008), 
with 13 people with scores under 30 (very low). WEMWBS scores showed a mean increase 
of 20.3% (p=0.000) (Stewart-Brown and Janmohamed, 2008). A meaningful change (≥5 
points) was seen in 54 people (62.9%).  Well-being Star showed an average improvement of 
43.3% (p=0.000). There was a 22.8% increase in PAM score, which equated to 0.7 of a PAM 
Level. Over half of users saw their PAM Level increase by 1 or more (45/81, 55.6%). 
 
The RCFS showed a decrease of 4.6% towards less frailty. A decrease in one or more levels 
was seen in 28 people (34.1%), 46 (56.1%) saw no change and 8 people (9.8%) saw an 
increase in frailty, 4 people by 3 levels.  
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Table 2. Mean change in health and social care outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
α Student’s Paired T-test  
β
 Wilcoxon Matched-Paired Signed-Rank Sum test 
Key: SD (Standard Deviation); 95% CI (95% Confidence Interval); WEMWBS (Warwick-Edinburgh Mental Well-being Scale); PAM (Patient Activation Measure); RCFS (Rockwood Clinical Frailty 
Scale). 
Variable N Mean score on 
entry (SD) 
(95% CI) 
Mean score at 12 
weeks (SD)  
(95% CI) 
Change in mean 
score (%) 
(95% CI) 
P-value 
WEMWBS 86 38.8 (10.3) 
(36.6-41.0) 
46.7 (10.9) 
(44.4-49.1) 
7.9 (20.3%) 
(6.1-9.7) 
0.000α 
Well-being Star™ 82 30.6 (12.6) 
(27.9-33.4) 
43.9 (13.3) 
(41.0-46.8) 
13.3 (43.3%) 
(10.6-15.9) 
0.000α 
PAM       
  Score  81 50.1 (11.7) 
(47.5-52.7) 
61.6 (16.9) 
(57.8-65.3) 
11.4 (22.8%) 
(8.6-14.3) 
0.000
β
 
  Level 81 1.8 (1.0) 2.6 (1.1) 0.7 (38.9%) 0.000
β
 
RCFS 82 4.8 (1.3) 4.5 (1.6) 0.2 (4.7%) 0.033
β
 
Goal achievement 85 3.2 (1.3) 0.5 (0.7) 2.7 (85.3%) 0.000
β
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Health and social care use 
The mean change in health and social care use is shown in Table 3. GP contact data were not 
included due to the poor quality of extracted data. The increase in mean health and social care 
use for all service types was only statistically significant for in-patient, community and social 
care. Most distributions were highly positively skewed towards 0, 1 or 2 contacts. A 
relatively small number of participants (10, 11.6%) accounted for a large proportion of the 
increase across the health and social care systems (79.4%). In social care, 64 (73.5%) people 
saw a decrease or no change in use whilst in health care it was 32 (37.2%).   
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Table 3. Mean change in health and social care use (n=86) 
 
 
 
 
 
 
 
 
 
 
 
 
α Wilcoxon Matched-Paired Signed-Rank Sum test 
Key: A&E (Accident and Emergency) 
Variable 
 
Average  contacts  
12 months before 
entry (range) 
Average  contacts 
12 months after 
entry (range) 
  
Change in mean 
score (%) 
 
P-valueα 
A&E    0.99 (0-7)     1.33 (0-6)    0.34 (34.0%) 0.137 
In-patient    1.19 (0-9)     1.99 (0-15)    0.80 (67.4%) 0.018 
Out-patient    4.06 (0-31)     4.52 (0-35)    0.46 (11.5%) 0.560 
Community    9.28 (0-81)   16.24 (0-96)    6.97 (75.1%) 0.001 
Social care  30.20 (0-730) 113.04 (0-1290)  82.84 (274.3%) 0.000 
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Health and social care costs 
Table 4 shows the sum and mean change in health and social care costs and the relative cost 
contributions.  
 
The total sum of health and social care cost before and after was £387,483 and £749,706 
respectively. Thus, there was an overall increase in costs of £362,223 (93.5%). This 
represented a change in mean cost of £4,212 per user, a statistically significant increase for 
health and social care. Although health care costs accounted for the majority of costs (85.3%) 
and the overall cost increase (59.9%), social care costs also increased, by more than two-fold. 
 
Just over half of users (55.8%, 48/86) saw an increase in costs (>£400), 15 (17.4%) saw no 
change (-£400 to £400) and 23 (26.7%) a reduction in costs (<-£400). Of those with an 
increased cost, 28 (29.2%) saw an increase >£5,000 per person.  
 
To further understand the large increase in cost we examined the records of 13 participants in 
one locality with costs >£5,000 (out of 28 overall), who accounted for 59.1% of the overall 
cost increase for all localities (£213,960 of £362,223). Ten were referred by intermediate care 
(three re-referrals) and three by the voluntary sector. The cases revealed that health costs 
accounted for 81.2% of the overall increase cost. The 10-fold increase largely resulted from 
hospitalisation (with an average change of 36 days) and increased contact with community 
services, due to an escalation in morbidity and frailty (and mental health for many), caused 
by degenerative or rare diseases, long-term conditions and discrete episodes like falls, urinary 
tract infections, sepsis and end of life care (4). Almost all the social care component was due 
to one young person who died unexpectedly from a rare condition, incurring a large social 
care cost (>£30,000). Case notes revealed that the Well-being Co-ordinators were acting as 
key workers in many cases, improving continuity of care, reducing social isolation, providing 
mental health and carer support during a difficult time. 
 
Influence of participants’ entry-level variables on health and social outcomes 
We explored the association between age bands (<75, 76-85, >85), sex, PAM Level (1-4) and 
RCFS score (1-9) on entry to the programme and meaningful change in WEMWBS score 
(≥5) and Well-being Star™ scores, in order to identify sub-groups who may benefit from the 
service more than others. 
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Table 4. Sum and mean change in health and social care costs 12 months before and after entry into the service  α  
 
Variable Sum of 
costs 
12 months 
before  
Sum of 
costs 
12 months 
after  
Change 
in costs  
Average 
cost 12 
months 
before  
Average 
cost 12 
months 
after 
  
Change 
in mean 
costs 
 
% 
change 
P-value β 
Health costs  £330,360 £547,510  £217,150  £3,841  £6,366 £2,525  66.7% 0.004β 
Social care costs   £57,123  £202,196 £145,073    £664   £2,351  £1,686  254.0% 0.000β 
Total cost £387,483 £749,706 £362,223  £4,506  £ 8,718 £4,212 93.5% 0.001β 
% change - - -   85.3%   73.0%   59.9% - - 
α
 Costs exclude GP contacts 
β
 Using the Wilcoxon Matched-Paired Signed-Rank Sum test
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Table 5 shows the proportion of users achieving meaningful change in WEMWBS (defined 
as ≥5 point change (Putz et al., 2012) across variables. Over 60% of participants showed 
meaningful change in WEMWBS by variable, with minor variation within category. For 
ordinal variables (age, PAM Level and RCFS score) the proportion of people with 
meaningful change was fairly consistent across sub-groups, and any variation seen was not 
statistically significant. There were similar results for nominal variables (sex and referral 
route), with sub-group variation not statistically significant. 
 
Predicting change in health and social outcomes, activity and cost with entry-level variables 
As the data was not normally distributed, binominal logistic regression models were 
developed to explore the influence of entry level variables, age, sex, PAM and RCFS score 
on  health care, social care and health and social care costs (<£400 and ≥£400). Only the 
change in social care cost regression model was statistically significant, with the RCFS score 
only explaining 24.6% of the variance (Nagelkerke R-squared test) and correctly classifying 
82.1% of cases. Increasing RCSF is likely to predict change in social care costs ≥£400 by 
2.49 times (95% CI: 1.43-4.33, p=0.001).
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Table 5. Association between meaningful change in health outcome and entry-level 
variables 
 
Variable  Number 
(n) 
Meaningful change in 
WEMWBS score (≥5) 
% with 
change 
(≥5) 
 
P-value 
 No Yes 
Sex n=86 32 54   62.8% 0.432α 
  Female 63 25 38   60.3%  
  Male  23 7 16   69.6%  
Age n=85 32 53   62.4% 0.928α 
  ≤75  26 9 17   65.4%  
    76-85 28 11 17   60.7%  
  >85 31 12 19   61.3%  
PAM Level n=81 29 52   64.2% 0.547
β
 
Level 1 42 15 27   64.3%  
Level 2 19   9 10   52.6%  
Level 3 14   4 10   71.4%  
Level 4   6   1   5   83.3%  
RCFS n=82 30 52   62.7% 0.752
β
 
≤3   7   2 5   71.4%  
  4 35 11 24   58.6%  
  5 11   5 6   54.5%  
≥6 29 12 17   69.4%  
Referral  route n=85 32 53   62.4% 0.371
β
 
GP 21 10 11   52.4%  
Hospital discharge   7   2   5   71.4%  
MDT 29 10 19   64.3%  
Other statutory   3   0   3 100.0%  
Staff referral   6   3   3   50.0%  
Social care   2   2   0   70.6%  
Voluntary sector 17   5 12   50.0%  
Referral  route 
(grouped) 
n=85 32 53   62.4% 0.499α 
Community 48 20 28   58.3%  
Complex  37 12 25   67.6%  
α X2 test 
β
 Fishers exact test 
 
Key: WEMWBS (Warwick-Edinburgh Mental Well-being Scale); MDT (Multi-Disciplinary Team meeting); Other 
statutory e.g. public health services 
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Discussion 
This before and after study evaluated the impact of a 12-week holistic link-worker 
intervention on people over 50 years-old with multiple long-term conditions, as part of a 
social prescribing programme in South Devon. Its aims were to reduce social isolation, 
improve health and activation, and to reduce the use of health and social care services. Our 
cohort was 73% female, elderly (nearly half older than 80 years) and frail with nearly half 
vulnerable, unable to manage many activities of daily living. The majority had been referred 
from intermediate care, general practice or the voluntary sector and were lowly activated to 
manage their health. Many were using out-patient or community services, with just over a 
quarter of participants in contact will all health and social care service types, accounting for 
two-thirds of all contacts (high-users). 
 
Most users achieved all their living-well goals set with Co-ordinators, and showed a 
statistically significant, meaningful change in their health and social care outcomes over the 
following 12 weeks. The largest mean change was in the Outcomes Star™, which given the 
magnitude is likely to have increased scores on most of its seven dimensions (such as looking 
after yourself, social participation and feeling positive). This was corroborated by an increase 
in WEMWBS, indicating improvements in people’s functioning, social relationships, sense of 
purpose as well as feelings of well-being and happiness (Fat et al., 2017).  
 
Over half of users saw an increase in their PAM level by 1 or more levels, suggesting that 
participants felt more able to manage their health condition, and a third saw improvement in 
frailty level by one or more. These changes were supported by many qualitative case studies 
that documented significant changes to peoples’ lives socially, physically and mentally, 
brought about by working with Co-ordinators to address their social, physical and economic 
needs.  
 
However, these positive changes were not accompanied by a uniform decrease in health and 
social care use. Although just under half of the cohort saw a decrease or no change in 
activity, on average there was an overall increase in activity and costs, significant for in-
patient, community and social care services. A significant proportion of this increase was 
accounted for by a rapid, escalation in morbidity and frailty in just over a dozen people. 
Given that most of this elderly cohort were referred by intermediate care, a rapid 
deterioration in health might not be unexpected, and not necessarily preventable by a 
predominantly bio-psychosocial intervention (Parkinson and Buttrick, 2015). 
 
Our primary findings emphasise the importance of better understanding the types of people 
who would benefit most from social prescribing. Our analysis of different categories of entry-
level variables showed some variation in health outcomes and service use, but with no 
discernible patterns or only weak, non statistically-significant associations. The exception 
was the RCFS score, which was positively correlated with change in social care costs, 
possibly explained by people becoming less mobile and able to manage the activities of daily 
living with time and, therefore, becoming more dependent on social support. This implies that 
participants reporting a reduction in their frailty, through being supported to be more socially 
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active and engaged, are associated with a relatively smaller increase in social care costs. In 
practice, our results suggest that the majority of older people over 50 with long-term 
conditions stand to benefit from holistic social prescribing irrespective of age, sex and levels 
of activation and frailty, including the frail elderly.  
 
Strengths and limitations of study 
This study was conceptually clearer than previous studies, with a specific focus on referrals 
receiving the holistic link-worker approach (rather than all referrals irrespective of input 
intensity). We included relevant outcomes not included in other studies – patient activation 
and frailty – that relate to assumed benefits of social prescribing. We had good participation 
and excellent follow-up rates in relation to outcomes and long-term follow-up of health and 
social care activity data and costs. This enabled us to assess the impact on health and social 
care use with greater certainty, with less concern for regression to the mean effects 
(Steventon et al., 2011; Murray, 2016) or the influence of seasonality (a potential issue when 
the first studied cohort service commenced in summer). Few studies have collected longer-
term data (Brandling J et al., 2011; Dayson and Bashir, 2014; Kimberlee R et al., 2014; 
Maughan et al., 2016) with such high-level follow-up (Grayer et al., 2008) or such a 
comprehensive range of acute, community and social care activity and cost data (Bickerdike 
et al., 2017). This allowed some provisional exploration of which patient characteristics on 
programme entry might be associated with positive outcomes. Although our numbers were 
small in some sub-categories (which may have under powered this element of the analysis), 
we are not aware of other studies that have done this. 
 
The lack of a control group means that we can only assume a tentative causal link between 
the intervention and the findings. Other studies have found improved outcomes and reduced 
activity in control groups (Bertotti et al., 2015; Murray, 2016), suggesting that the findings 
could be biased positively. Conversely, in a relatively frail, elderly cohort where an increase 
in health and social care activity is more likely, a control group could have helped determine 
how much was prevented. The large variation in triage rates might suggest different criteria 
were being used in practice. There was no outcome or attendance data for activities collected 
at 12 months, which would have strengthened causal claims between the intervention and 
change in health and social care use. Data quality issues precluded an analysis of GP contacts 
data. Local costings were used (based on a national methodology) rather than unit cost data 
(Curtis and Burns, 2016) more typically used in economic evaluations. However, we present 
the costs used in our calculations so as to facilitate comparison with other studies. We did not 
include the average cost per person of the holistic element of the Well-being Coordination 
Service (which cost £165,500 and managed 1,046 referrals in the first year) as contact time 
was not recorded, nor the wider societal benefits of the programme (e.g. increased 
employment, access to benefits or volunteering) required to estimate Social Return On 
Investment (Dayson and Bashir, 2014). 
  
Comparison with existing literature 
The magnitude and direction of improvement in health and well-being outcomes is broadly 
supportive of other studies (Murray, 2016), including those with stronger designs, but few 
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studies have used WEMWBS (Murray, 2016) or Outcomes Star, and lack of sufficient detail 
to allow direct comparisons (Friedli et al., 2012). 
 
Social prescribing is often targeted at all ages, often in more deprived communities. This 
programme is unusual in focusing on people over 50 years old with two or more long-term 
conditions. We are only aware of a few evaluations that report similar median ages to our 
study (Dayson and Bashir, 2014; Windle et al., 2016), but these have not captured the impact 
on frailty. Over 50% of our cohort was mildly or moderately frail, many referred by their GP 
or the MDT. Our study indicates a potentially small but significant impact, shifting people 
from mildly frail to vulnerable, or dependency on others for their activities of daily living to 
greater confidence, mobility and independence.  
 
Frailty is not a static classification; it can become better or worse (British Geriatrics Society, 
2014). Evidence suggests that addressing mobility, social isolation and loneliness, physical 
activity and low mood, through interventions like social prescribing, can reduce severity and 
improve outcomes (British Geriatrics Society, 2014). Ensuring integrated community and 
primary care to support people with frailty is advocated nationally (Baker et al., 2016). This 
study supports the emerging evidence base on innovations in this area, and suggests that 
reversing frailty could have positive consequences for the cost of social care.  
 
Implications for research and practice 
There are only two studies (of which we are aware) that have assessed the impact of social 
prescribing on patient activation (using PAM) (Mendip, 2016; Bertotti et al., 2017). Like our 
study, these showed positive improvements in participants’ levels of activation to manage 
their long-term health condition, many from a low level, but also those at higher activation 
levels. However, our study had high-levels of follow-up, reducing the risk of a positive bias, 
and was statistically significant for score and level. The smaller effects seen in Bertotti et al’s 
(2017) study might be explained by the use of ‘light touch’ rather than ‘holistic’ link-workers 
or differences in the referred cohort. People who are less activated are less receptive to 
preventative advice and care, less active in decisions about their care, and adhere less to 
treatment regimens (Hibbard et al., 2013). As we did not review clinical indicators, our 
findings only partially support the assumption in national policy that social prescribing 
improves patients’ self-management.  PAM is also of interest to national policy-makers 
because it can be used as a predictor of current and future health and social care costs 
(Hibbard et al., 2013). However, our study did not find such an association. 
 
Evidence on social prescribing reducing health and social care activity is generally favourable 
(Polley et al., 2017a), but only two studies had a control group (Bertotti et al., 2015; Murray, 
2016), with follow-up at 4 and 12 months. In contrast to this study, evaluations show 
reductions in A&E attendance (8%-26.8%), emergency admissions (6%-33.6%), secondary 
care referrals (55%). This did not appear to be the case in our study, with a small cohort of 
people, mostly referred from intermediate care (rather than general practice), subsequently 
experiencing a rapid deterioration in health, accounting for much of the increase. As other 
studies analysed all link-worker referrals together and had low rates of follow-up (Dayson 
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and Bashir, 2014), it is possible that these results were positively biased, with those people 
having a positive experience of social prescribing being more likely to be followed up. The 
study with a least risk of bias (a randomised controlled study) saw a doubling of referrals to 
mental health service (Grant et al., 2000).  Larger controlled-studies with good follow-up are 
now required to assess the impact of a link-worker on the frail, elderly, in order to determine 
whether policy in this area should be developed. 
 
Conclusion 
This study focused on the impact of ‘holistic’ link-working, as part of a wider social 
prescribing service mainly offering ‘lighter touch’ link-working – the approach typically 
reported in UK studies. It showed improved quality of life, patient activation and reduced 
frailty in a complex cohort with multiple long-term conditions. Just under half of referrals 
saw a decrease or no change in cost and activity after 12 months. For those with an increase, 
this was primarily due to a small group of people experiencing a rapid deterioration in health. 
Further, controlled studies are needed to strengthen claims of causality.        
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